OnePURE PROCESS

Since our establishment in 2021, our mission has been to enhance lives by utilizing superior processes with an unwavering dedication to innovation. Leveraging our proprietary OnePURE Processing™ method, we manufacture perinatal tissue allografts at the highest levels of quality. Our OnePURE Processing™ was developed to apply the latest research in restorative medicine to preserve and maintain natural tissue structure and growth factors.

During the tissue recovery and OnePURE Processing™ steps, every pre-caution is taken to ensure that the patient will receive safe, high quality 361 HCTP Tissue Allografts. Before being released, extensive donor screening and laboratory testing is performed using CLIA Certified laboratories. All donor tissue recovery and processing criteria meet both FDA 21 CFR 1271 regulations and AATB Standards requirements for each HCT/P product type. One Biologics products are manufactured under strict controls and quality assurance.